Long-Term Opioid Prescriptions Fall By About A Quarter

Follow Drugslib on

By Dennis Thompson HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on April 14, 2026.

via HealthDay

TUESDAY, April 14, 2026 — Long-term opioid prescriptions have declined dramatically in the United States, reflecting progress made against America’s opioid epidemic, a new study says.

Patients on active long-term opioid treatment – defined as 90 days or longer – fell by nearly a quarter (24%) between 2015 and 2023, researchers recently reported in the Journal of the American Medical Association.

But more than 4 million Americans still have a long-term opioid prescription, putting them at ongoing risk of overdose, researchers warned.

“Nearly 1 in 9 patients receiving prescription opioids were still chronic opioid users in 2023, highlighting the importance of developing and implementing evidence-based guidelines for chronic pain management,” lead researcher Thuy Nguyen said in a news release. She’s an assistant professor of health management and policy at the University of Michigan School of Public Health.

For the study, researchers analyzed trends in U.S. opioid use using a database that captures 92% of all American retail pharmacy prescriptions.

Results showed that in 2023, patients on long-term opioid therapy accounted for just under 12% of all patients prescribed any opioids.

Overall, the number of people on long-term opioids fell from about 5.6 million in 2015 to 4.2 million in 2023.

Researchers also observed a shift in those receiving long-term opioid therapy. Average patient age rose from nearly 53 in 2015 to almost 61 in 2023.

In addition, Medicare now covers the most long-term opioid prescriptions, increasing from about 39% in 2015 to 49% in 2023.

Average daily doses of long-term opioids have decreased, declining from about 48 morphine milligram equivalents in 2015 to just under 39 in 2023.

Doctors also have been more cautious prescribing opioids long-term with benzodiazepines, researchers found.

Co-prescriptions with benzodiazepines declined from 44% in 2015 to 34% in 2023, the study showed. This drug combination dramatically increases a person’s risk of overdose.

However, co-prescriptions increased with other drugs.

Gabapentinoid prescriptions alongside long-term opioids rose from 47% to 59%, researchers found. Gabapentinoids are used to treat nerve pain, and do not carry the same overdose risk as benzodiazepine drugs.

These results show there’s a pressing need to develop better ways to treat pain, said senior researcher Dr. Pooja Lagisetty, an associate professor of internal medicine at the University of Michigan Medical School.

“With almost 5 million Americans on long-term prescription opioids for chronic pain, and likely millions more who are taking shorter courses of prescription opioids for acute pain, most clinicians are likely to care for someone using prescription opioids for pain highlighting the pressing importance for investing in better treatment models for pain,” Lagisetty said.

Sources

  • University of Michigan School of Public Health, news release, April 8, 2026

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2026-04-15 02:08

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords